Eczema Trial, Recruiting (NCT05611346)

Eczema Trial, Recruiting NCT05611346 Sponsor: Centre Hospitalier Universitaire de la Réunion Condition: Eczema

Printed from Voxsanity (voxsanity.com.au) — NCT05611346 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Eczema

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children between 8 and 17 years old
Children who understand and speak French
Children who have been diagnosed with atopic dermatitis (eczema), ranging from mild to severe
Children who have been referred by their doctor to the eczema education program at the Reunion University Hospital
Children whose parent or legal guardian has given verbal agreement for them to take part, and who have also agreed themselves

Who may not be able to join:

Children who do not want to take part in a hypnosis session
Children who are not able to listen to an audio file (for example, due to hearing difficulties or lack of access to a device)
Children who are already using self-hypnosis to manage their eczema before joining the trial
Children who have a medical reason why hypnosis is not suitable for them, such as certain mental health conditions (confirm with trial site)
Children who are currently taking oral or injected (systemic) medication to treat their eczema

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Juliette MIQUEL, MD, CHU de la Réunion

Phone: +262 262 35 90 00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05611346

Sponsor: Centre Hospitalier Universitaire de la Réunion

Phase: Not Applicable

Status: Recruiting

Condition: Eczema

Trial contact: +262 262 35 90 00

More information: https://clinicaltrials.gov/study/NCT05611346

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children between 8 and 17 years old
Children who understand and speak French
Children who have been diagnosed with atopic dermatitis (eczema), ranging from mild to severe
Children who have been referred by their doctor to the eczema education program at the Reunion University Hospital
Children whose parent or legal guardian has given verbal agreement for them to take part, and who have also agreed themselves

Who may not be able to join:

Children who do not want to take part in a hypnosis session
Children who are not able to listen to an audio file (for example, due to hearing difficulties or lack of access to a device)
Children who are already using self-hypnosis to manage their eczema before joining the trial
Children who have a medical reason why hypnosis is not suitable for them, such as certain mental health conditions (confirm with trial site)
Children who are currently taking oral or injected (systemic) medication to treat their eczema

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Universitaire de la Réunion

Registry

ClinicalTrials.gov

Start date

13 August 2024

Est. completion

1 February 2027

Where this trial is recruiting

Reunion

Primary endpoints

Asses the patient recruitment rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov